Central Nervous System Neoplasms

"Central Nervous System Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.

Descriptor ID	D016543
MeSH Number(s)	C04.588.614.250 C10.551.240
Concept/Terms	Central Nervous System Neoplasms Central Nervous System Neoplasms Neoplasms, Central Nervous System Tumors, Central Nervous System Central Nervous System Tumors Central Nervous System Neoplasms, Primary Central Nervous System Neoplasms, Primary Primary Central Nervous System Neoplasms

Below are MeSH descriptors whose meaning is more general than "Central Nervous System Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Nervous System Neoplasms [C04.588.614]
Central Nervous System Neoplasms [C04.588.614.250]
Nervous System Diseases [C10]
Nervous System Neoplasms [C10.551]
Central Nervous System Neoplasms [C10.551.240]

Below are MeSH descriptors whose meaning is related to "Central Nervous System Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Central Nervous System Neoplasms" by people in this website by year, and whether "Central Nervous System Neoplasms" was a major or minor topic of these publications.

Bar chart showing 8 publications over 8 distinct years, with a maximum of 1 publications in 2006 and 2010 and 2012 and 2014 and 2015 and 2018 and 2019 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2006	1	0	1
2010	1	0	1
2012	1	0	1
2014	1	0	1
2015	1	0	1
2018	1	0	1
2019	0	1	1
2020	1	0	1

Below are the most recent publications written about "Central Nervous System Neoplasms" by people in Profiles.

Bhaskaran M, Devegowda VG, Gupta VK, Shivachar A, Bhosale RR, Arunachalam M, Vaishnavi T. Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme. ACS Chem Neurosci. 2020 10 07; 11(19):2962-2977.

View in: PubMed
van Iersel L, Li Z, Srivastava DK, Brinkman TM, Bjornard KL, Wilson CL, Green DM, Merchant TE, Pui CH, Howell RM, Smith SA, Armstrong GT, Hudson MM, Robison LL, Ness KK, Gajjar A, Krull KR, Sklar CA, van Santen HM, Chemaitilly W. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes. J Clin Endocrinol Metab. 2019 12 01; 104(12):6101-6115.

View in: PubMed
Frazer JK, Li KJ, Galardy PJ, Perkins SL, Auperin A, Anderson JR, Pinkerton R, Buxton A, Gross TG, Michon J, Leverger G, Weinstein HJ, Harrison L, Shiramizu B, Barth MJ, Goldman SC, Patte C, Cairo MS. Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1. Br J Haematol. 2019 04; 185(2):374-377.

View in: PubMed
Shiramizu B, Goldman S, Smith L, Agsalda-Garcia M, Galardy P, Perkins SL, Frazer JK, Sanger W, Anderson JR, Gross TG, Weinstein H, Harrison L, Barth MJ, Mussolin L, Cairo MS. Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report. Br J Haematol. 2015 Aug; 170(3):367-71.

View in: PubMed
Goldman S, Smith L, Galardy P, Perkins SL, Frazer JK, Sanger W, Anderson JR, Gross TG, Weinstein H, Harrison L, Shiramizu B, Barth M, Cairo MS. Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report. Br J Haematol. 2014 Nov; 167(3):394-401.

View in: PubMed
Cruz-Mu?oz W, Jaramillo ML, Man S, Xu P, Banville M, Collins C, Nantel A, Francia G, Morgan SS, Cranmer LD, O'Connor-McCourt MD, Kerbel RS. Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma. Cancer Res. 2012 Oct 01; 72(19):4909-19.

View in: PubMed
Ramos-Vara JA, Miller MA, Gilbreath E, Patterson JS. Immunohistochemical detection of CD34, E-cadherin, claudin-1, glucose transporter 1, laminin, and protein gene product 9.5 in 28 canine and 8 feline meningiomas. Vet Pathol. 2010 Jul; 47(4):725-37.

View in: PubMed
Koul D, Shen R, Bergh S, Sheng X, Shishodia S, Lafortune TA, Lu Y, de Groot JF, Mills GB, Yung WK. Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma. Mol Cancer Ther. 2006 Mar; 5(3):637-44.

View in: PubMed

People

Explore

Similar Concepts

Top Journals